10 CFOs in Pharmaceuticals

Experience: Chief Financial Officer · BeOne Medicines

Chief Financial Officer at BeOne Medicines since July 2024; the profile describes BeOne as a pharmaceutical manufacturing company focused on global cancer care. Before that he held finance leadership roles at Merck, including Vice President Finance, Merck Animal Health CFO (2015–2018), Senior Vice President, Corporate Strategy and Planning (2019–2021) and Senior Vice President Finance, Corporate Treasurer (2021–2024).

Experience: Executive Director Finance & Chief Financial Officer, Pfizer Ltd · Pfizer

Executive Director Finance & Chief Financial Officer, Pfizer Ltd at Pfizer since February 2024. Before Pfizer he held finance roles at Unilever from 2015 to 2024, including Finance Controller - Global Business Services (2016–2020), General Manager - Internal Audit (2020–2022) and General Manager Finance - Sales & Customer Development (2022–2024).

Experience: EVP & Chief Financial Officer · Collegium Pharmaceutical, Inc.

EVP & Chief Financial Officer at Collegium Pharmaceutical, Inc. since May 2021; the profile describes Collegium as a diversified specialty pharmaceutical company. Before that she was Senior Vice President & CFO, U.S. Business Unit at Takeda (2019–2021) and held vice president finance roles at Shire from 2015 to 2019, including Vice President, US Commercial Finance (2016–2019).

Experience: Chief Financial Officer · Pharmacosmos Therapeutics Inc.

Chief Financial Officer at Pharmacosmos Therapeutics Inc. since April 2023; the profile describes Pharmacosmos as a privately held, Denmark-headquartered specialty pharmaceutical company focused on iron deficiency, with Pharmacosmos US as its US distribution arm. Before that she held finance roles at Novartis, including Head of Finance Cardio-Renal-Metabolic Business Unit (2017–2022) and Vice President Finance (2022–2023).

Experience: EVP & Chief Financial Officer · Catalyst Pharmaceuticals, Inc.

EVP & Chief Financial Officer at Catalyst Pharmaceuticals, Inc. since January 2024. Earlier CFO roles include Chief Financial Officer and Chief Accounting Officer, Group V.P. at Taro Pharmaceuticals (2009–2016), SVP & Chief Financial Officer at Amarin Corporation (2016–2022), EVP & Chief Financial Officer at CinCor Pharma, Inc. (2022–2023) and Chief Financial Officer at Impel Pharmaceuticals (2023).

Experience: Chief Financial Officer · AstraZeneca

Chief Financial Officer at AstraZeneca since March 2022, based in São Paulo, Brazil, and also listed as Executive Controller at AstraZeneca from 2020 to 2022. Before AstraZeneca she was FP&A & Commercial Finance Executive Director Transition Leader at GE HealthCare (2015–2020) and CFO, Wind Latin America at GE (2010–2015).

Experience: Executive Vice President, Chief Financial Officer · AbbVie

Executive Vice President, Chief Financial Officer at AbbVie since November 2022, having held the Senior Vice President, Chief Financial Officer title earlier in 2022; the profile says he is responsible for AbbVie's global financial and business technology operations. Earlier AbbVie roles include Vice President, Tax (2013–2019) and Vice President, Tax and Treasury (2019–2022), and he joined Abbott's finance organization in 2008.

Experience: Chief Financial Officer · Alexion Pharmaceuticals, Inc.

Chief Financial Officer at Alexion Pharmaceuticals, Inc. since August 2021; the profile describes Alexion as a global biopharmaceutical company. Before that he held finance roles at AstraZeneca, including CFO Gulf States (2011–2012), Area Finance Director - Middle East & Africa (2012–2015), CFO China & Hong Kong (2015–2018) and VP Finance R&D (2018–2021).

Experience: Senior Vice President, Finance and Chief Financial Officer · ANI Pharmaceuticals, Inc.

Senior Vice President, Finance and Chief Financial Officer at ANI Pharmaceuticals, Inc. since May 2016. Before that he held controller roles at Par Health from 2007 to 2015, from Vice President and Controller to Senior Vice President, Corporate Controller and Principal Accounting Officer, and earlier was Director of Finance, EUCAN at Merck (2005–2007).

Experience: Chief Financial Officer · Sanofi India Limited

Chief Financial Officer at Sanofi India Limited since October 2020, after finance roles at the company dating from 2007. These include Associate Director Accounting & Direct tax (2007–2012), Director Accounting & Direct Tax (2012–2014), Director Accounting & Taxation (2014–2016) and Sr. Director Finance at Sanofi India Ltd (2016–2020).